Bone Disease in Thyrotoxicosis

Overview

Journal Indian J Med Res

Specialty General Medicine

Date 2012 May 8

PMID 22561612

Citations 21

Authors

P Amaresh Reddy

C V Harinarayan

Alok Sachan

V Suresh

G Rajagopal

Affiliations

Soon will be listed here.

Abstract

Thyrotoxicosis, a clinical syndrome characterized by manifestations of excess thyroid hormone, is one of the commonly-recognised conditions of the thyroid gland. Thyrotoxicosis causes acceleration of bone remodelling and though it is one of the known risk factors for osteoporosis, the metabolic effects of thyroxine on bone are not well discussed. Studies show that thyroid hormones have effects on bone, both in vitro and in vivo. Treatment of thyrotoxicosis leads to reversal of bone loss and metabolic alterations, and decreases the fracture risk. There are limited studies in India as to whether these changes are fully reversible. In this review we discuss about the effects of thyrotoxicosis (endogenous and exogenous) on bone and mineral metabolism, effects of subclinical thyrotoxicosis on bone and mineral metabolism and effects of various forms of treatment in improving the bone mineral density in thyrotoxicosis.

Citing Articles

Radiomorphometric Parameters in Mandibular Panoramic Radiographs of Hypothyroid Patients: A Cross-Sectional Study.

Nair A, Patil V, Bhardwaj I, Singhal D, Smriti K, Chhaparwal Y Clin Cosmet Investig Dent. 2025; 17():31-37.

PMID: 39830592 PMC: 11742241. DOI: 10.2147/CCIDE.S502528.

foxe1 mutant zebrafish show indications of a hypothyroid phenotype and increased sensitivity to ethanol for craniofacial malformations.

Raterman S, Wagener F, Zethof J, Cuijpers V, Klaren P, Metz J Dev Dyn. 2024; 254(3):240-256.

PMID: 39360443 PMC: 11877993. DOI: 10.1002/dvdy.745.

The impact of thyroid function on total spine bone mineral density in postmenopausal women.

Ji J, Li Z, Xue L, Xue H, Wen T, Yang T Endocrine. 2024; 85(1):279-286.

PMID: 38308787 DOI: 10.1007/s12020-024-03712-8.

Bone microarchitecture and bone mineral density in Graves' disease.

Boro H, Malhotra R, Kubihal S, Khatiwada S, Dogra V, Mannar V Osteoporos Sarcopenia. 2023; 9(2):70-75.

PMID: 37496984 PMC: 10366428. DOI: 10.1016/j.afos.2023.05.001.

Is thyroid disease associated with post-operative complications after total joint arthroplasty? A systematic review of the literature.

Tsotsolis S, Kenanidis E, Pegios V, Potoupnis M, Tsiridis E EFORT Open Rev. 2023; 8(2):54-62.

PMID: 36805936 PMC: 9969002. DOI: 10.1530/EOR-22-0085.

References

Frizel D, MALLESON A, Marks V . Plasma levels of ionised calcium and magnesium in thyroid disease. Lancet. 1967; 1(7504):1360-1. DOI: 10.1016/s0140-6736(67)91766-7. View

Ross D, Ardisson L, Nussbaum S, Meskell M . Serum osteocalcin in patients taking L-thyroxine who have subclinical hyperthyroidism. J Clin Endocrinol Metab. 1991; 72(2):507-9. DOI: 10.1210/jcem-72-2-507. View

Stall G, Harris S, Sokoll L, Dawson-Hughes B . Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine. Ann Intern Med. 1990; 113(4):265-9. DOI: 10.7326/0003-4819-113-4-265. View

TOH S, CLAUNCH B, Brown P . Effect of hyperthyroidism and its treatment on bone mineral content. Arch Intern Med. 1985; 145(5):883-6. View

Stock J, SURKS M, OPPENHEIMER J . Replacement dosage of L-thyroxine in hypothyroidism. A re-evaluation. N Engl J Med. 1974; 290(10):529-33. DOI: 10.1056/NEJM197403072901001. View

Thomas F, Caldwell J, Greenberger N . Steatorrhea in thyrotoxicosis. Relation to hypermotility and excessive dietary fat. Ann Intern Med. 1973; 78(5):669-75. DOI: 10.7326/0003-4819-78-5-669. View

Faber J, Jensen I, Petersen L, Nygaard B, Hegedus L, Siersbaek-Nielsen K . Normalization of serum thyrotrophin by means of radioiodine treatment in subclinical hyperthyroidism: effect on bone loss in postmenopausal women. Clin Endocrinol (Oxf). 1998; 48(3):285-90. DOI: 10.1046/j.1365-2265.1998.00427.x. View

Diamond T, Nery L, HALES I . A therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma. J Clin Endocrinol Metab. 1991; 72(6):1184-8. DOI: 10.1210/jcem-72-6-1184. View

Bassett J, OShea P, Sriskantharajah S, Rabier B, Boyde A, Howell P . Thyroid hormone excess rather than thyrotropin deficiency induces osteoporosis in hyperthyroidism. Mol Endocrinol. 2007; 21(5):1095-107. DOI: 10.1210/me.2007-0033. View

10.

Dash S, Jain S, Khanna K, GREWAL K . Thyrotoxicosis, renal tubular acidosis and renal stone. J Assoc Physicians India. 1980; 28(9):323-5. View

11.

Hanna F, Pettit R, Ammari F, Evans W, Sandeman D, Lazarus J . Effect of replacement doses of thyroxine on bone mineral density. Clin Endocrinol (Oxf). 1998; 48(2):229-34. DOI: 10.1046/j.1365-2265.1998.3871200.x. View

12.

. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1994; 843:1-129. View

13.

Franklyn J, Maisonneuve P, Sheppard M, Betteridge J, Boyle P . Mortality after the treatment of hyperthyroidism with radioactive iodine. N Engl J Med. 1998; 338(11):712-8. DOI: 10.1056/NEJM199803123381103. View

14.

Amato G, Mazziotti G, Sorvillo F, Piscopo M, Lalli E, Biondi B . High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment. Bone. 2004; 35(3):785-91. DOI: 10.1016/j.bone.2004.04.021. View

15.

Wejda B, Hintze G, Katschinski B, Olbricht T, Benker G . Hip fractures and the thyroid: a case-control study. J Intern Med. 1995; 237(3):241-7. DOI: 10.1111/j.1365-2796.1995.tb01172.x. View

16.

Kim D, Khang Y, Koh J, Shong Y, Kim G . Low normal TSH levels are associated with low bone mineral density in healthy postmenopausal women. Clin Endocrinol (Oxf). 2006; 64(1):86-90. DOI: 10.1111/j.1365-2265.2005.02422.x. View

17.

Meier C, Beat M, Guglielmetti M, Christ-Crain M, Staub J, Kraenzlin M . Restoration of euthyroidism accelerates bone turnover in patients with subclinical hypothyroidism: a randomized controlled trial. Osteoporos Int. 2004; 15(3):209-16. DOI: 10.1007/s00198-003-1527-8. View

18.

Szeto C, Chow C, Li K, Ko T, Yeung V, Cockram C . Thyrotoxicosis and renal tubular acidosis presenting as hypokalaemic paralysis. Br J Rheumatol. 1996; 35(3):289-91. DOI: 10.1093/rheumatology/35.3.289. View

19.

Guo C, Weetman A, Eastell R . Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine. Clin Endocrinol (Oxf). 1997; 46(3):301-7. DOI: 10.1046/j.1365-2265.1997.1280950.x. View

20.

Franklyn J, Betteridge J, Holder R, Daykin J, Lilley J, Sheppard M . Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis. Clin Endocrinol (Oxf). 1994; 41(4):425-32. DOI: 10.1111/j.1365-2265.1994.tb02572.x. View